Puma Shares Soar on Breast-Cancer Therapy Study Results

Puma Biotechnology Inc. said its investigational breast-cancer treatment showed a 33% improvement in disease-free survival over a placebo in a phase III study.



from WSJ.com: US Business http://ift.tt/1mBtKuV

via IFTTT